According to the full results of the latest phase of the test, the vaccine against covide-19 of the American biotechnology company Moderna has an activity of over 94 percent, even in cases of the disease even a pedal 100%. Studies did not show high-voltage bottoms. The company is going to go to the regulation of the series in the United States and the European Union on Monday to approve the extraordinary use of the substance.
According to Pfizer, Vaccine Moderny could be the second to receive US ad permission this year. Pfizer filed enough with the US Food and Drug Administration (FDA) ten days ago. Independent advisers are required by the FDA to share their recommendations regarding the Pfizer vaccine on December 10, when the Modern vaccine will meet a week later.
We believe that we have a vaccine that has a very high activity. Now we have the data to prove it, said the research director of Tal Zaks. We hope that we will play a key role in turning this pandemic to better, he added.
In addition to the FDA, Moderna wants to apply for an extraordinary permit to the European Medicines Agency (EMA), which has started to analyze some data regarding its vaccination.
The activity report announced on Monday is three tenths of a percent lower than the value that the company stated in mid-November with reference to the preliminary results. According to Zakse, the bag is a statistically insignificant difference.
Compared to Pfizer, the modern company has the advantage that the warehouse does not have to be in extremely low temperatures, and will therefore be easy to distribute to the patients themselves. They do not lose their activity even at temperatures, they are in normal domestic frosts.
The company tested the vaccine on 30,000 people, using only an innocent substance called placebo. A total of 196 people became ill with Covidem-19 during the test, 185 of them in the groups received placebo, and the remaining 11 were inoculated. 30 people developed the tk form of covid-19, all of whom were from the group that received the innocent. Thus, the vaccine has a 100% activity in the previous form of the disease, a hard society, which pays, for example, the sexes and age and ethnic groups.
Even the final results did not show the so-called inca lkka. The most common were nava, pain in the city of vaccine application, as well as headaches and muscle aches. All these effects are just a short run. For some people, the lice caused symptoms similar to lace, but they did not endanger them in any way.
Modern claims that it could have produced 20 million doors in the USA by the end of this year, which is worth about ten million people. Last week, the European Commission approved a contract with Moderna for the purchase and 160 million vaccinations.
–
–
